Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling of BRAF in a Large Series of Lung Cancer Samples Translational research - Lung and other thoracic tumours
27 Sep 2015 ESMO Commentary: Atezolizumab Set to Change Refractory Lung Cancer Treatment Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
16 Sep 2015 Advanced Treatment and Prognosis Data Available for TNM Classification of Lung Cancer Lung and other thoracic tumours
14 Sep 2015 Study Defines Criteria for MET-driven Lung Cancer Suitable for Crizotinib Treatment Translational research - Lung and other thoracic tumours
20 Aug 2015 FDA Approves a Laboratory Immunohistochemical Test That Identifies Whether the ALK Protein is Present in a NSCLC Tissue Sample Pathology/Molecular biology - Lung and other thoracic tumours
30 Jul 2015 EMA Recommends Granting a Marketing Authorisation for Pemetrexed Lilly and Pemetrexed Sandoz Lung and other thoracic tumours - Anticancer agents & Biologic therapy
17 Jul 2015 FDA Approves Gefitinib for First-Line Treatment of Patients with Metastatic NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
07 Jul 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Docetaxel Hospira UK Limited Breast cancer - Genitourinary cancers - Lung and other thoracic tumours - Head and neck cancers - Gastrointestinal cancers - Anticancer agents & Biologic therapy
02 Jun 2015 Nivolumab vs Docetaxel in Advanced Non-Squamous Cell NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab in Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
22 Apr 2015 Pembrolizumab Shows Antitumour Activity in Patients with Advanced NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
17 Apr 2015 ELCC 2015 News: Detection of EGFR T790M Mutation from Circulating Tumour DNA in Urine of Patients with Metastatic NSCLC Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available Bioethics, legal and economic issues - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: DNA Blood Test Detects Lung Cancer Mutations Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: Smokers Underestimate Risks of a Few Cigarettes Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours